S. Sundar, F. Rosenkaimer, M. K. Makharia, A. K. Goyal, A. K. Mandal et al., Trial of oral miltefosine for visceral leishmaniasis, Lancet, vol.352, pp.1821-1823, 1998.

S. Sundar and H. W. Murray, Availability of miltefosine for the treatment of kala-azar in India, Bull. World Health Organ, vol.83, pp.394-395, 2005.

S. Sundar, T. K. Jha, C. P. Thakur, J. Engel, H. Sindermann et al., Oral miltefosine for Indian visceral leishmaniasis, N. Engl. J. Med, vol.347, pp.1739-1746, 2002.

A. Breiser, D. J. Kim, E. Fleer, W. Damenz, A. Drube et al., Distribution and metabolism of hexadecylphosphocholine in mice, Lipids, vol.22, pp.925-926, 1987.

N. Marschner, J. Kö-tting, H. Eibl, and C. Unger, Distribution of hexadecylphosphocholine and octadecyl-methyl-glycero-3-phosphocholine in rat tissues during steady-state treatment, Cancer Chemother. Pharmacol, vol.31, pp.18-22, 1992.

J. Kotting, N. W. Marschner, W. Neumuller, C. Unger, and H. Eibl, Hexadecylphosphocholine and octadecyl-methyl-glycero-3-phosphocholine: a comparison of hemolytic activity, serum binding and tissue distribution, Prog. Exp. Tumor Res, vol.34, pp.131-142, 1992.

I. , R. Gomez-serranillos, J. Minones, P. Dynarowicz-latka, E. Iribarnegaray et al., Study of the p-A isotherms of miltefosine monolayers spread at the air/water interface, Phys. Chem. Chem. Phys, vol.6, pp.1580-1586, 2004.

C. Matos, H. Chaimovich, J. L. Lima, I. M. Cuccovia, and S. Reis, Effect of liposomes on the rate of alkaline hydrolysis of indomethacin and acemetacin, J. Pharm. Sci, vol.90, pp.298-309, 2001.

P. S. De-araujo, M. Y. Rosseneu, J. M. Kremer, E. J. Van-zoelen, and G. H. De-haas, Structure and thermodynamic properties of the complexes between phospholipase A2 and lipid micelles, Biochemistry, vol.18, pp.580-586, 1979.

J. Kotting, N. W. Marschner, C. Unger, and H. Eibl, Determination of alkylphosphocholines and of alkyl-glycero-phosphocholines in biological fluids and tissues, Prog. Exp. Tumor Res, vol.34, pp.6-11, 1992.

D. R. Hoffman, L. H. Hoffman, and F. Snyder, Cytotoxicity and metabolism of alkyl phospholipid analogues in neoplastic cells, Cancer Res, vol.46, pp.5803-5809, 1986.

W. J. Van-blitterswijk, H. Hilkmann, and G. A. Storme, Accumulation of an alkyl lysophospholipid in tumor cell membranes affects membrane fluidity and tumor cell invasion, Lipids, vol.22, pp.820-823, 1987.

F. J. Perez-victoria, F. Gamarro, M. Ouellette, and S. Castanys, Functional cloning of the miltefosine transporter. A novel Ptype phospholipid translocase from Leishmania involved in drug resistance, J. Biol. Chem, vol.278, pp.49965-49971, 2003.

P. Artursson, Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells, J. Pharm. Sci, vol.79, pp.476-482, 1990.

I. J. Hidalgo, T. J. Raub, and R. T. Borchardt, Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability, Gastroenterology, vol.96, pp.736-749, 1989.

C. C. Geilen, A. Samson, T. Wieder, H. Wild, and W. Reutter, Synthesis of hexadecylphospho[methyl-14C]-choline, J. Labelled Compd. Radiopharm, vol.31, pp.1071-1076, 1992.

H. Eibl and P. Woolley, A general synthetic method for enantiomerically pure ester and ether lysophospholipids, Chem. Phys. Lipids, vol.47, pp.63-68, 1988.

T. Mosmann, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Methods, vol.65, pp.55-63, 1983.

T. Decker and M. L. Lohmann-matthes, A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity, J. Immunol. Methods, vol.115, pp.61-69, 1988.

C. Mé-nez, M. Buyse, H. Chacun, R. Farinotti, and G. Barratt, Modulation of intestinal barrier properties by miltefosine, Biochem. Pharmacol, vol.71, pp.486-496, 2006.

B. L. Clarke and P. H. Weigel, Recycling of the asialoglycoprotein receptor in isolated rat hepatocytes. ATP depletion blocks receptor recycling but not a single round of endocytosis, J. Biol. Chem, vol.260, pp.128-133, 1985.

P. Artursson and C. Magnusson, Epithelial transport of drugs in cell culture. II: Effect of extracellular calcium concentration on the paracellular transport of drugs of different lipophilicities across monolayers of intestinal epithelial (Caco-2) cells, J. Pharm. Sci, vol.79, pp.595-600, 1990.

L. S. Gan, P. H. Hsyu, J. F. Pritchard, and D. Thakker, Mechanism of intestinal absorption of ranitidine and ondansetron: transport across Caco-2 cell monolayers, Pharm. Res, vol.10, pp.1722-1725, 1993.

V. Pade and S. Stavchansky, Estimation of the relative contribution of the transcellular and paracellular pathway to the transport of passively absorbed drugs in the Caco-2 cell culture model, Pharm. Res, vol.14, pp.1210-1215, 1997.

A. Tsuji, H. Takanaga, I. Tamai, and T. Terasaki, Transcellular transport of benzoic acid across Caco-2 cells by a pH-dependent and carrier-mediated transport mechanism, Pharm. Res, vol.11, pp.30-37, 1994.

M. E. Cavet, M. West, and N. L. Simmons, Transepithelial transport of the fluoroquinolone ciprofloxacin by human airway epithelial Calu-3 cells, Antimicrob. Agents Chemother, vol.41, pp.2693-2698, 1997.

P. Artursson, A. L. Ungell, and J. E. Lofroth, Selective paracellular permeability in two models of intestinal absorption: cultured monolayers of human intestinal epithelial cells and rat intestinal segments, Pharm. Res, vol.10, pp.1123-1129, 1993.

L. S. Gan, T. Niederer, C. Eads, and D. Thakker, Evidence for predominantly paracellular transport of thyrotropin-releasing hormone across Caco-2 cell monolayers, Biochem. Biophys. Res. Commun, vol.197, pp.771-777, 1993.

I. J. Hidalgo and R. T. Borchardt, Transport of bile acids in a human intestinal epithelial cell line, Caco-2, Biochim. Biophys. Acta, vol.1035, pp.97-103, 1990.

M. Rybczynska, R. Liu, P. Lu, F. J. Sharom, E. Steinfels et al., MDR1 causes resistance to the antitumour drug miltefosine, Br. J. Cancer, vol.84, pp.1405-1411, 2001.

H. M. Said, A. Ortiz, and T. Y. Ma, A carrier-mediated mechanism for pyridoxine uptake by human intestinal epithelial Caco-2 cells: regulation by a PKAmediated pathway, Am. J. Physiol. Cell Physiol, vol.285, pp.1219-1225, 2003.

A. Leroy, G. K. De-bruyne, L. C. Oomen, and M. M. Mareel, Alkylphospholipids reversibly open epithelial tight junctions, Anticancer Res, vol.23, pp.27-32, 2003.

P. D. Ward, H. Ouyang, and D. R. Thakker, Role of phospholipase C-beta in the modulation of epithelial tight junction permeability, J. Pharmacol. Exp. Ther, vol.304, pp.689-698, 2003.

D. Z. Liu, E. L. Lecluyse, and D. R. Thakker, Dodecylphosphocholine-mediated enhancement of paracellular permeability and cytotoxicity in Caco-2 cell monolayers, J. Pharm. Sci, vol.88, pp.1161-1168, 1999.

A. Amelsberg, C. D. Schteingart, J. Stein, W. J. Simmonds, G. A. Sawada et al., Intestinal absorption of sodium dodecyl sulfate in the rodent: evidence for paracellular absorption, Am. J. Physiol, vol.272, pp.498-506, 1997.

D. E. Leahy, J. Lynch, R. E. Finney, and D. C. Taylor, Estimation of sieving coefficients of convective absorption of drugs in perfused rat jejunum, J. Pharmacokinet. Biopharm, vol.22, pp.411-429, 1994.

H. N. Nellans, Mechanisms of peptide and protein absorption : (1) Paracellular intestinal transport: modulation of absorption, Adv. Drug Deliv. Rev, vol.7, pp.339-364, 1991.

J. R. Pappenheimer, M. L. Karnovsky, and J. E. Maggio, Absorption and excretion of undegradable peptides: role of lipid solubility and net charge, J. Pharmacol. Exp. Ther, vol.280, pp.292-300, 1997.

V. Pade and S. Stavchansky, Link between drug absorption solubility and permeability measurements in Caco-2 cells, J. Pharm. Sci, vol.87, pp.1604-1607, 1998.

P. Artursson, K. Palm, and K. Luthman, Caco-2 monolayers in experimental and theoretical predictions of drug transport, Adv. Drug Deliv. Rev, vol.46, pp.27-43, 2001.

E. Biganzoli, L. A. Cavenaghi, R. Rossi, M. C. Brunati, and M. L. Nolli, Use of a Caco-2 cell culture model for the characterization of intestinal absorption of antibiotics, Il Farmaco, vol.54, pp.594-599, 1999.

K. M. Hillgren, A. Kato, and R. T. Borchardt, In vitro systems for studying intestinal drug absorption, Med. Res. Rev, vol.15, pp.83-109, 1995.

J. Berman, Miltefosine to treat leishmaniasis, Expert Opin. Pharmacother, vol.6, pp.1381-1388, 2005.

B. Arnold, R. Reuther, and H. U. Weltzien, Distribution and metabolism of synthetic alkyl analogs of lysophosphatidylcholine in mice, Biochim. Biophys. Acta, vol.530, pp.47-55, 1978.

P. K. Hanson, L. Malone, J. Birchmore, and J. Nichols, Lem3p is essential for the uptake and potency of alkylphosphocholine drugs, edelfosine and miltefosine, J. Biol. Chem, vol.278, pp.36041-36050, 2003.

F. J. Perez-victoria, S. Castanys, and F. Gamarro, Leishmania donovani resistance to miltefosine involves a defective inward translocation of the drug, Antimicrob. Agents Chemother, vol.47, pp.2397-2403, 2003.

E. E. Kelley, E. J. Modest, and C. P. Burns, Unidirectional membrane uptake of the ether lipid antineoplastic agent edelfosine by L1210 cells, Biochem. Pharmacol, vol.45, pp.2435-2439, 1993.

F. Uberall, H. Oberhuber, K. Maly, J. Zaknun, L. Demuth et al., Hexadecylphosphocholine inhibits inositol phosphate formation and protein kinase C activity, Cancer Res, vol.51, pp.807-812, 1991.

E. C. Heesbeen, G. Rijksen, H. G. Van-heugten, and L. F. Verdonck, Influence of serum levels on leukemic cell destruction by the ether lipid ET-18-OCH3, Leuk. Res, vol.19, pp.417-425, 1995.